Recurrence of ductopenic rejection in liver allografts after retransplantation for vanishing bile duct syndrome

Transplant Proc. 1991 Feb;23(1 Pt 2):1442-3.

Authors

B van Hoek¹, R H Wiesner, J Ludwig, C Paya

Affiliation

¹ Liver Transplantation Unit, Mayo Clinic, Rochester, Minnesota 55905.

PMID: 1703343

No abstract available

MeSH terms

Anti-Bacterial Agents / therapeutic use
Azathioprine / therapeutic use
Bile Ducts / pathology
Graft Rejection
Graft Survival
Humans
Immunosuppressive Agents
Liver Transplantation / pathology*
Risk Factors
Tacrolimus

Substances

Anti-Bacterial Agents
Immunosuppressive Agents
Azathioprine
Tacrolimus